lol @ the normalized earnings after the Vioxx write down, that is just pathetic IMO. There won't be a Vioxx case every year that they'll profit from in normal circumstances.
ROE declining, sits at about 10% now. I wonder what their ROC is with all the debt they have? It's probably lucky to be above their cost of capital, it's too close for comfort IMO.
lol @ the normalized earnings after the Vioxx write down, that...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)